Digital applications for on-body devices discussed at Wearable Injectors and Connected Devices conference 2021 Read more
Teva and MedinCell Announce FDA Acceptance of New Drug Application for TV-46000/mdc-IRM as a Treatment for Patients with Schizophrenia Read more
Senhwa’s Silmitasertib, COVID-19 Drug Candidate, Receives Positive Interim Review from Data Monitoring Committee to Proceed Read more
Data from Multiple Studies Show Positive Outcomes with Gala Therapeutics’ RheOx System for Chronic Bronchitis Read more
Epygenix Therapeutics Announces FDA Acceptance of IND to Initiate a Clinical Trial of EPX-100 to Treat Lennox-Gastaut Syndrome Read more
UCB Announces BRIVIACT (brivaracetam) CV Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older Read more
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer Read more
Novartis sabatolimab receives orphan drug designation from the European Commission for myelodysplastic syndromes Read more